Infections associated with medical intervention: hepatitis viruses and HGV

被引:0
作者
Carman, WF [1 ]
机构
[1] Univ Glasgow, Inst Virol, Glasgow G11 5JR, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transfusion and other medical interventions, as well as their non-medical derivatives, have a lot to answer for. Much of HCV infection can be traced back to this route, HGV is still being transmitted in this way and a substantial proportion of HBV in Africa has been spread around by use of contaminated skin-piercing manoeuvres, medical or otherwise. Many practitioners can still remember the days when blood-borne viruses were not a major feature of medical curricula. Unfortunately, patients currently subjected to cost-cutting medical practices, for example use of unscreened blood and re-use of needles, will have to pay the price in years to come. The evolution of these viruses is linked to their route of introduction, but the relationship between variability and clinical outcome is less certain. Nevertheless, variability is important for clinical practice, especially for the design of sensitive diagnostics and highly effective vaccines.
引用
收藏
页码:731 / 748
页数:18
相关论文
共 73 条
  • [1] AKARCA US, 1994, HEPATOLOGY, V19, P1366
  • [2] Sequential changes in full-length genomes of hepatitis B virus accompanying acute exacerbation of chronic hepatitis B
    Asahina, Y
    Enomoto, N
    Ogura, Y
    Kurosaki, M
    Sakuma, I
    Izumi, N
    Marumo, F
    Sato, C
    [J]. JOURNAL OF HEPATOLOGY, 1996, 25 (06) : 787 - 794
  • [3] Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication
    Baumert, TF
    Rogers, SA
    Hasegawa, K
    Liang, TJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (10) : 2268 - 2276
  • [4] Bollyky P., 1997, Journal of Hepatology, V26, P67
  • [5] BOLLYKY PL, UNPUB EVIDENCE DIREC
  • [6] BOLLYKY PL, 1997, HEPATOLOGY AASLD S, V26, P756
  • [7] High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection
    Bozkaya, H
    Ayola, B
    Lok, ASF
    [J]. HEPATOLOGY, 1996, 24 (01) : 32 - 37
  • [8] Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma
    Brechot, C
    [J]. HEPATOLOGY, 1997, 25 (03) : 772 - 774
  • [9] PRECORE SEQUENCE VARIATION IN CHINESE ISOLATES OF HEPATITIS-B VIRUS
    CARMAN, WF
    FERRAO, M
    LOK, ASF
    MA, OCK
    LAI, CL
    THOMAS, HC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) : 127 - 133
  • [10] VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS
    CARMAN, WF
    ZANETTI, AR
    KARAYIANNIS, P
    WATERS, J
    MANZILLO, G
    TANZI, E
    ZUCKERMAN, AJ
    THOMAS, HC
    [J]. LANCET, 1990, 336 (8711) : 325 - 329